New Pharmaceutical Strategy for Europe – your input is requested!

Stella Kyriakides, European Commission commissioner for Health and Food Safety recently announced that “the Pharmaceutical Strategy for Europe is a cornerstone of our policy in the area of health for the next five years, and this is the chance for all stakeholders to help us shape it. “

Europe’s pharmaceutical sector is a major contributor to the EU economy in terms of creation of highly skilled jobs and investment in innovation, and now members of the public, healthcare professionals and providers, academia, researchers and the pharmaceutical industry are invited to contribute by completing an online questionnaire which will help guide the new Pharmaceutical Strategy for Europe

Coming in the wake of the COVID-19 pandemic, the strategy will also inform the newly proposed EU4Health Programme and align with Horizon Europe to create a “future proof” system which reaps the benefits of digitalisation and promotes innovation, especially in areas of unmet needs such as antimicrobials, medicines for children and medicines for rare diseases.

Find out more, and complete the questionnaire here.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.